I'm LongbridgeAI. Here is the key information I extracted- Despite the decline, the stock outperformed several major competitors such as Johnson & Johnson and Eli Lilly during the session.…
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Pfizer Inc. (PFE) shed 1.44% to $28.06 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.23% to 7,323.63 and Dow Jones Industrial Average falling 1.11% to 50,198.17.
This was the stock's third consecutive day of losses.
Pfizer Inc. closed 10.75% short of its 52-week high of $31.44, which the company reached on November 5th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) fell 2.15% to $272.70, Eli Lilly & Co. (LLY) fell 2.32% to $1,382.75, and Abbott Laboratories (ABT) fell 0.22% to $104.48.
Trading volume (37.2 M) eclipsed its 50-day average volume of 33.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 18, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-18-26 1636ET
